![Edmund Olivier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edmund Olivier
Direktor/Vorstandsmitglied bei
EGeen International Corp.
Profil
Edmund Martin Olivier is the founder of Oxford Bioscience Partners, which was founded in 1992.
He held the title of Senior General Partner from 2011 to 2015.
Mr. Olivier currently holds director positions at EGeen International Corp., South Coast Repertory, and The Salk Institute for Biological Studies.
He is also a Managing Partner & General Partner at Poscap Ventures LLC since 2013.
Mr. Olivier's former positions include Managing Director-Europe at Conoco, Inc. from 1965 to 1972, Vice President at Diamond Shamrock, Inc., VP & GM-Worldwide Scientific Products Division at Corning, Inc. from 1972 to 1980, Director at Trans-India Acquisition Corp.
from 2006 to 2009, Independent Director at Ceres, Inc. (California) from 1996 to 2014, Director at Astex Therapeutics Ltd., Director at Ventureast Fund Advisors (India) Ltd., Partner at Coastview Capital LLC, and Venture Partner at Biobank Technology Ventures.
Mr. Olivier received his undergraduate degree from Rice University and his MBA degree from Harvard Business School.
Aktive Positionen von Edmund Olivier
| Unternehmen | Position | Beginn |
|---|---|---|
EGeen International Corp.
 EGeen International Corp. Pharmaceuticals: MajorHealth Technology Provides drugs and medical services | Direktor/Vorstandsmitglied | - |
South Coast Repertory
 South Coast Repertory Media ConglomeratesConsumer Services Operates live theatre | Direktor/Vorstandsmitglied | - |
The Salk Institute for Biological Studies
 The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Poscap Ventures LLC
 Poscap Ventures LLC Miscellaneous Commercial ServicesCommercial Services Develops biotechnologies | Private Equity Investor | 01.01.2013 |
Ehemalige bekannte Positionen von Edmund Olivier
| Unternehmen | Position | Ende |
|---|---|---|
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations. | Gründer | 30.05.2015 |
| CERES INC | Direktor/Vorstandsmitglied | 07.03.2014 |
Trans-India Acquisition Corp.
 Trans-India Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Direktor/Vorstandsmitglied | 06.04.2009 |
Coastview Capital LLC
 Coastview Capital LLC Investment ManagersFinance Coastview Capital seeks to identify promising new drug candidates and bottlenecks in the drug discovery process. They look for companies that are working to create new product opportunities and new technologies to improve drug discovery and drug discovery processes. When evaluating a company they look for the following components: innovative, breakthrough science, a top management team, able to build the right mix of science and business capabilities, products and technology platforms that address real pharmaceutical industry needs, market and commercial potential and a strong current or potential intellectual property position. Coastview invests across all stages of development, although their current focus is primarily on later-stage companies. The firm considers investments in all geographical areas, depending on their investment criteria being met and the involvement of other key investors. Initial investments range from $1 million to $5 million and up to a total of $10 million over the life of the company. Their preferred regions for investments are Southern California, Boston, the San Francisco Bay area and the greater Washington DC area. | Corporate Officer/Principal | 30.06.2006 |
| CORNING INCORPORATED | Corporate Officer/Principal | 01.01.1980 |
Ausbildung von Edmund Olivier
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
79
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Corning, Inc.
 Corning, Inc. Electronic ComponentsElectronic Technology Manufactures specialty glass and ceramics | Electronic Technology |
Diamond Shamrock, Inc.
 Diamond Shamrock, Inc. Oil Refining/MarketingEnergy Minerals Crude oil refining & natural gas processi | Energy Minerals |
The Salk Institute for Biological Studies
The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford Bioscience Partners
Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations. | Finance |
Conoco, Inc.
 Conoco, Inc. Oil Refining/MarketingEnergy Minerals Explores, refines and sells crude oil, natural gas & related lubricants | Energy Minerals |
Trans-India Acquisition Corp.
Trans-India Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ceres, Inc. (California)
 Ceres, Inc. (California) Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit driving sustainability via investor and corporate networks for climate action, water stewardship and nature restoration | Commercial Services |
Astex Therapeutics Ltd.
 Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops fragment based drug | Health Technology |
EGeen International Corp.
EGeen International Corp. Pharmaceuticals: MajorHealth Technology Provides drugs and medical services | Health Technology |
Coastview Capital LLC
Coastview Capital LLC Investment ManagersFinance Coastview Capital seeks to identify promising new drug candidates and bottlenecks in the drug discovery process. They look for companies that are working to create new product opportunities and new technologies to improve drug discovery and drug discovery processes. When evaluating a company they look for the following components: innovative, breakthrough science, a top management team, able to build the right mix of science and business capabilities, products and technology platforms that address real pharmaceutical industry needs, market and commercial potential and a strong current or potential intellectual property position. Coastview invests across all stages of development, although their current focus is primarily on later-stage companies. The firm considers investments in all geographical areas, depending on their investment criteria being met and the involvement of other key investors. Initial investments range from $1 million to $5 million and up to a total of $10 million over the life of the company. Their preferred regions for investments are Southern California, Boston, the San Francisco Bay area and the greater Washington DC area. | Finance |
Biobank Technology Ventures
 Biobank Technology Ventures Investment ManagersFinance Biobank Technology invests in companies across the globe. The firm targets the companies operating in the fields of the life sciences sectors. It provide financing for seed and early-stage transactions. | Finance |
Ventureast Fund Advisors (India) Ltd.
 Ventureast Fund Advisors (India) Ltd. Investment ManagersFinance Ventureast Fund Advisors (India) Ltd invests in technology companies located in India. The firm targets companies operating in the fields of deep tech, product software, B2B and fintech sector and industries. The firm provides financing for seed and early-stage capital requirements with an investment size ranging from USD 2 to 5 million. | Finance |
South Coast Repertory
South Coast Repertory Media ConglomeratesConsumer Services Operates live theatre | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Poscap Ventures LLC
Poscap Ventures LLC Miscellaneous Commercial ServicesCommercial Services Develops biotechnologies | Commercial Services |
